Molecular model of the Covid-19 drug Nirmatrelvir (red) binding to and inhibiting the the 3C-like protease (blue) of the SARS-CoV-2 virus. Nirmatrelvir is an antiviral medication developed to treat Covid-19, which is caused by the SARS-CoV-2 virus. 3C-like protease, also known as main protease, processes two long polyproteins that the virus needs to replicate new viruses.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG33249849
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: